Literature DB >> 11054454

Predicting residue solvent accessibility from protein sequence by considering the sequence environment.

O Carugo1.   

Abstract

The solvent accessibility of each residue is predicted on the basis of the protein sequence. A set of 338 monomeric, non-homologous and high-resolution protein crystal structures is used as a learning set and a jackknife procedure is applied to each entry. The prediction is based on the comparison of the observed and the average values of the solvent-accessible area. It appears that the prediction accuracy is significantly improved by considering the residue types preceding and/or following the residue whose accessibility must be predicted. In contrast, the separate treatment of different secondary structural types does not improve the quality of the prediction. It is furthermore shown that the residue accessibility is much better predicted in small than in larger proteins. Such a discrepancy must be carefully considered in any algorithm for predicting residue accessibility.

Mesh:

Substances:

Year:  2000        PMID: 11054454     DOI: 10.1093/protein/13.9.607

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  12 in total

1.  Electron spin-labelling of the EutC subunit in B12-dependent ethanolamine ammonia-lyase reveals dynamics and a two-state conformational equilibrium in the N-terminal, signal-sequence-associated domain.

Authors:  Benjamen Nforneh; Adonis M Bovell; Kurt Warncke
Journal:  Free Radic Res       Date:  2017-12-18

2.  Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1.

Authors:  Susan E Ivie; Mark S McClain
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

3.  Real value prediction of protein solvent accessibility using enhanced PSSM features.

Authors:  Darby Tien-Hao Chang; Hsuan-Yu Huang; Yu-Tang Syu; Chih-Peng Wu
Journal:  BMC Bioinformatics       Date:  2008-12-12       Impact factor: 3.169

4.  Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance.

Authors:  Miyoung Lee; David Shorthouse; Robert Mahen; Benjamin A Hall; Ashok R Venkitaraman
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

5.  Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380-389) of HSP90 beta protein.

Authors:  Eusebio S Pires; Asmita K Choudhury; Susan Idicula-Thomas; Vrinda V Khole
Journal:  Reprod Biol Endocrinol       Date:  2011-01-27       Impact factor: 5.211

6.  Recognition of interaction interface residues in low-resolution structures of protein assemblies solely from the positions of C(alpha) atoms.

Authors:  Rupali A Gadkari; Deepthi Varughese; N Srinivasan
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

7.  A generic method for assignment of reliability scores applied to solvent accessibility predictions.

Authors:  Bent Petersen; Thomas Nordahl Petersen; Pernille Andersen; Morten Nielsen; Claus Lundegaard
Journal:  BMC Struct Biol       Date:  2009-07-31

8.  Prediction of protein-protein interaction sites in sequences and 3D structures by random forests.

Authors:  Mile Sikić; Sanja Tomić; Kristian Vlahovicek
Journal:  PLoS Comput Biol       Date:  2009-01-30       Impact factor: 4.475

9.  Context dependent reference states of solvent accessibility derived from native protein structures and assessed by predictability analysis.

Authors:  Hemajit Singh; Shandar Ahmad
Journal:  BMC Struct Biol       Date:  2009-04-27

10.  Logistic regression models to predict solvent accessible residues using sequence- and homology-based qualitative and quantitative descriptors applied to a domain-complete X-ray structure learning set.

Authors:  Reecha Nepal; Joanna Spencer; Guneet Bhogal; Amulya Nedunuri; Thomas Poelman; Thejas Kamath; Edwin Chung; Katherine Kantardjieff; Andrea Gottlieb; Brooke Lustig
Journal:  J Appl Crystallogr       Date:  2015-11-10       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.